Peter Freed, managing director of Cirrus Real Time Processing Systems, has pinpointed some key benefits for companies specialising in offering military simulation services around digitisation and advances in software technology.
Freed told Defence Connect’s Phillip Tarrant that while he was hesitant to predict how the sector might evolve over the next two decades, a major change his firm had seen over the past 20 years centred on a shift from proprietary military hardware systems to software implementations of niche applications.
“That change actually makes the task for an organisation like ours, which seeks to represent what is going on within military systems, substantially more straightforward,” said Freed.
“We can build software which runs on standard computer equipment, which does a very good job of representing what is going on in these large military systems.”
In addition, Freed noted a substantial lift in defence business generally at the moment.
“We're already seeing growth in our business with the types of projects which have gone onto the market, and which Cirrus has been fortunate enough to secure,” he said.
“So we do have growth in our engineering team and our capability, [and] I’m very pleased about that.”
Freed also touched on the question of how best to approach the defence vertical for those SMEs keen to gain entry into that burgeoning market.
“There is no easy pathway into a stable piece of defence business,” he explained. “Credibility has to be established, small businesses in the defence space will be confronted with a very difficult chicken and egg problem … they can't establish their credibility until they get to do serious contracts, and they don't get to do serious contracts until they have credibility.
“How individual businesses manage to get through that particular chicken and egg problem will be essentially up to the leaders of those businesses.”
Subscribe to the Defence Connect daily newsletter.
Be the first to hear the latest developments in the defence industry.
To hear more from Cirrus MD Peter Freed, tune in to our podcast here.